English Українська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    O. A. Shaposhnyk, N. P. Prykhodko, L. V. Savchenko, T. I. Shevchenko, S. I. Sorokina, L. I. Yakymyshyna, I. P. Kudria

    CLINICAL AND DIAGNOSTIC ASPECTS OF MANAGING PATIENTS WITH VALVULAR HEART DISEASE


    About the author: O. A. Shaposhnyk, N. P. Prykhodko, L. V. Savchenko, T. I. Shevchenko, S. I. Sorokina, L. I. Yakymyshyna, I. P. Kudria
    Heading CLINICAL MEDICINE
    Type of article Scentific article
    Annotation The article presents the results of examination of 47 patients with valvular heart disease. According to the research findings, when investigating the causes of severe mitral regurgitation, especially in young and middle-aged people, one should primarily consider Barlow's disease, myxomatous mitral valve degeneration, as the primary cause (having excluded fibroelastic deficiency). It was found that among all cases of detected mitral valve prolapse (even minor or moderate), which is currently diagnosed quite often with the development of modern technology, stratification of patients requires additional examinations to identify people at high risk of disease progression and complications, as well as to determine the prognosis.
    Tags valvular heart disease, diagnosis, treatment methods, prognosis optimization
    Bibliography
    • Bogachev-Prokofyev AV, Afanasyev AV, Zhuravleva IJu, Demidov DP, Zheleznev SI, Malakhova OJu. Patologiya mitralnogo klapana pri displazii soedinitelnoy tkani. Ros. kardiologicheskiy zhurn. 2016;(11):81–6. https://doi.org/10.15829/1560-4071-2016-11-81-86. [in Russian]
    • Mokhnatyi SI, Dovhan OM. Otsiniuvannia faktoriv, shcho vplyvaiut na viddaleni rezultaty khirurhichnoho likuvannia vyrazhenoyi mitralnoyi nedostatnosti pry prolapsi mitralnoho klapana. Ukr. zhurn. sertsevo-sudynnoyi khirurhiyi. 2019;4:28–35. [in Ukrainian]
    • Pavliuk VI, Korotash TI, Povaliashko LV, Myshakivskyi OA. Mitralna nedostatnist: otsiniuvannia metodom cherezstravokhidnoyi ekhokardiohrafiyi. Kardiokhirurhiya ta interventsiyna kardiolohiya. 2017;4:36–44. [in Ukrainian]
    • Rubanenko AO, Dyachkov VA, Shhukin JuV, Rubanenko OA, Jurchenko IN. Priobretennye poroki serdtsa: klinicheskaya kartina, diagnostika. Kardiologiya: novosti, mneniya, obuchenie. 2019;7(3):26–36. doi:10.24411/2309-1908-2019-13003. [in Russian]
    • Shevchenko TI, Shaposhnyk OA, Sorokina SI, Kudria IP, Yefremenko VM. Osoblyvosti vedennya patsiientiv z pizno diahnostovanoyu vrodzhenoyu vadoyu sertsia. Svit medytsyny ta biolohii. 2019;1(67):111–16. DOI 10.26724/2079-8334-2019-1-67-111 [in Ukrainian]
    • Ahmed M, Roshdy A, Sharma R, Fletcher N. Sudden cardiac arrest and coexisting mitral valve prolapse: a case report and literature review. Echo Res Pract. 2016;3:1–8. doi: 10.1530/ERP-15-0020.
    • Chekalina NI, Kazakov YM, Mamontova TV et al. Resveratrol more effectively than quercetin reduces endothelium degeneration and level of necrosis factor α in patients with coronary artery disease. Wiadomosci Lekarskie. 2016; 69(3): 475–479.
    • Gammie JS, Chikwe J, Badhwar V, Thibault DP, Vemulapalli S, Thourani VH, et al. Isolated mitral valve surgery: the society of thoracic surgeons adult cardiac surgery Database analysis. Ann Thorac Surg. 2018 Sep;106(3):716–27. doi: 10.1016/j.athoracsur.2018.03.086.
    • Nishimura RA, Vahanian A, Eleid MF, Mack MJ. Mitral valve disease-current management and future challenges. Lancet. 2016;387(10025):1324–34. DOI: 10.1016/S0140-6736(16)00558-4.
    • Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2021 Aug 28:395. doi: 10.1093/eurheartj/ehab395.
    Publication of the article «World of Medicine and Biology» №2(80), 2022 year, 178-183 pages, index UDK 616.126-002-071
    DOI 10.26724/2079-8334-2022-2-80-178-183